Silent Heart Attack Raises Cerebral Infarction Risk
|
By HospiMedica International staff writers Posted on 06 Jun 2019 |
A new study reveals that asymptomatic (silent) heart attacks are associated with double the risk of cardiac embolism and stroke of undetermined cause.
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Latest Critical Care News
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
- Cancer-Seeking Microbubbles Make Tumor Cells Self-Destruct
- Eye Movement Tests Uncover Hidden Brain Changes Years After Concussion
- Simple 5-Minute Questionnaire Test Speeds Endometriosis Diagnosis
- Nanohydrogels Guide Medicine to Tumors Without Damaging Healthy Tissue
- Magnetic Gel Offers Safer and More Effective Atrial Fibrillation Treatment
- Hydrogel Biosensor Detects and Differentiates Blood Circulation Complications
- Spray-Type Technology Coats Transplant Organs with Immunosuppressants to Prevent Rejection
- Single Heart Attack Shot to Revolutionize Cardiac Care
Channels
Artificial Intelligence
view channel
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
AI Tool Maps Early Risk Patterns in Bloodstream Infections
Bloodstream infections can deteriorate rapidly and carry high mortality, especially in immunocompromised patients. Clinicians need reliable early risk stratification to prioritize monitoring and organ support.... Read moreSurgical Techniques
view channel
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Handheld Robotic System Expands Options for Total Knee Surgery
Orthopedic teams vary in their adoption of robotics, with some surgeons favoring intraoperative decision-making and a manual instrument feel, while others rely on preoperative, computed tomography–based... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channelMedtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
Medtronic announced a multiyear renewal and significant expansion of its global strategic alliance with GE HealthCare across Patient Care Solutions. Building on more than three decades of collaboration,... Read more
Quantum Surgical Acquires NeuWave from Johnson & Johnson
Quantum Surgical announced that it has acquired NeuWave Medical from Johnson & Johnson. NeuWave’s microwave ablation system is used in percutaneous tumor ablation procedures, and the acquisition supports... Read more
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more







